Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SusmedTSE:4263 59 Cash Ratio is 34.61 as of Mar. 2026, which is 54% above its 10-year median of 22.47. GuruFocus rates TSE:4263 with a GF Score™ of 59/100 and a GF Value™ of 円904.60 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 657 Healthcare Providers & Services companies, Susmed ranks better than 99.54% on this metric.
The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Susmed's Cash Ratio for the quarter that ended in Mar. 2026 was 34.61.
Susmed has a Cash Ratio of 34.61. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.
The historical rank and industry rank for Susmed's Cash Ratio or its related term are showing as below:
TSE:4263'
s Cash Ratio Range Over the Past 10 Years
Min: 15.08 Med: 22.47 Max: 55.93
Current: 25
During the past 7 years, Susmed's highest Cash Ratio was 55.93. The lowest was 15.08. And the median was 22.47.
TSE:4263's Cash Ratio is ranked better than 99.54% of 657
companies
in the Healthcare Providers & Services industry
Industry Median: 0.56
vs TSE:4263: 25.00
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Susmed Cash Ratio Related Terms
Susmed Cash Ratio Historical Data
* Premium members only.
The historical data trend for Susmed's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4263 vs VEEV, BTSG, HQY: Cash Ratio Comparison
For the Health Information Services subindustry, Susmed's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Susmed Cash Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Susmed's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Susmed's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Susmed (TSE:4263) has a Cash Ratio of 34.61 as of Mar. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Susmed and its competitors. This is 54% above median its historical median of 22.47. Over the past decade, Susmed's Cash Ratio has ranged from 15.08 to 55.93. According to the industry distribution chart, Susmed ranks #3 out of 657 companies in the Healthcare Providers & Services industry, placing it in the top 0.5%.
Is Susmed's Cash Ratio too high?
Susmed's current Cash Ratio of 34.61 is 54% above median its 10-year median of 22.47. Over the past 10 years, this metric has ranged from a low of 15.08 to a high of 55.93. The Healthcare Providers & Services industry median Cash Ratio is 0.56. Susmed's value of 34.61 is 6080.4% above this industry median. Based on the distribution chart, Susmed ranks #3 out of 657 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Susmed has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Susmed's Cash Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Susmed ranks #3 out of 657 companies for Cash Ratio. This places Susmed in the top 1% of its industry — outperforming the majority of peers. The industry median Cash Ratio is 0.56. Susmed's value of 34.61 is 6080.4% above this benchmark. Historically, Susmed's own Cash Ratio has ranged from 15.08 to 55.93 over the past decade. While the company's 10-year median is 22.47 vs. the industry median of 0.56, Susmed has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Healthcare Providers & Services company?
The median Cash Ratio among Healthcare Providers & Services companies is 0.56, based on 657 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Susmed's current Cash Ratio of 34.61 is 6080.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Susmed and its competitors. For the Healthcare Providers & Services industry, the median Cash Ratio is 0.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Susmed's current Cash Ratio is 34.61, which is 54% above median its own 10-year median of 22.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Susmed stock overvalued right now?
Based on GuruFocus' analysis, Susmed (TSE:4263) is currently considered Possible Value Trap. The stock's GF Value™ is 円904.60, compared to a current price of 円569.00 — trading 37.1% below its estimated fair value. The current Cash Ratio is 34.61, which is 54% above median its 10-year median of 22.47 and 6080.4% above the Healthcare Providers & Services industry median of 0.56. Susmed's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Susmed (TSE:4263), the current Cash Ratio is 34.61 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Susmed (TSE:4263) Overvalued in 2026?
Based on GuruFocus' analysis, Susmed stock appears to be undervalued.
The current stock price of 円569.00 is trading 37.1% below its estimated GF Value™ of 円904.60.
GuruFocus considers Susmed to be Possible Value Trap.
Key valuation signals for TSE:4263:
Cash Ratio: 34.61 (54% above median its 10-year median of 22.47)
GF Value™: 円904.60 vs. price of 円569.00 (37.1% below fair value)
Industry Position: 6080.4% above the Healthcare Providers & Services median (#3 of 657)
No single metric tells the full story. See the TSE:4263 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Susmed Inc is engaged in the development of therapeutic smartphone apps and digital solutions to streamline clinical trials. It is currently developing therapeutic apps for patients with insomnia, breast cancer, kidney disease, and other conditions. In addition, it has developed Susumed System, which uses a proprietary blockchain technology to ensure the reliability of clinical trial data, and can reduce the manpower and costs allocated to clinical trials. The company's reportable segments are: the DTx Product Business, which derives maximum revenue, and consists of the development of therapeutic apps; and the DTx Platform Business, which provides general-purpose clinical trial systems and machine learning automated analysis systems.
59GF Score
Get the complete analysis for TSE:4263
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4263 has been successfully added to your 
